Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 12 | 2025 | 1128 | 2.690 |
Why?
|
| Biliary Atresia | 6 | 2025 | 205 | 1.730 |
Why?
|
| Zellweger Syndrome | 1 | 2024 | 16 | 0.920 |
Why?
|
| Immunosuppressive Agents | 4 | 2025 | 695 | 0.910 |
Why?
|
| Polyneuropathies | 1 | 2024 | 32 | 0.910 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2025 | 58 | 0.890 |
Why?
|
| Cholestasis | 1 | 2025 | 158 | 0.800 |
Why?
|
| Herpesvirus 6, Human | 1 | 2021 | 55 | 0.700 |
Why?
|
| Graft Rejection | 5 | 2025 | 629 | 0.650 |
Why?
|
| Liver Diseases | 2 | 2024 | 390 | 0.640 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2018 | 19 | 0.600 |
Why?
|
| Blood Group Incompatibility | 1 | 2018 | 27 | 0.590 |
Why?
|
| Organ Transplantation | 1 | 2021 | 186 | 0.590 |
Why?
|
| ABO Blood-Group System | 1 | 2018 | 68 | 0.580 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2017 | 15 | 0.570 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 229 | 0.570 |
Why?
|
| Neonatal Screening | 1 | 2019 | 193 | 0.560 |
Why?
|
| Hepatitis B, Chronic | 1 | 2018 | 86 | 0.550 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2017 | 129 | 0.520 |
Why?
|
| Cytokines | 1 | 2023 | 1396 | 0.520 |
Why?
|
| Immunologic Memory | 1 | 2017 | 199 | 0.510 |
Why?
|
| Capsule Endoscopy | 2 | 2012 | 20 | 0.470 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 629 | 0.460 |
Why?
|
| Contrast Media | 2 | 2024 | 513 | 0.460 |
Why?
|
| Child | 18 | 2025 | 25762 | 0.440 |
Why?
|
| Alagille Syndrome | 2 | 2025 | 49 | 0.430 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 373 | 0.430 |
Why?
|
| Transplant Recipients | 3 | 2023 | 225 | 0.370 |
Why?
|
| Constipation | 1 | 2012 | 126 | 0.360 |
Why?
|
| DNA, Viral | 2 | 2024 | 501 | 0.360 |
Why?
|
| Humans | 28 | 2025 | 133564 | 0.300 |
Why?
|
| Postoperative Complications | 2 | 2018 | 3160 | 0.300 |
Why?
|
| Chickenpox Vaccine | 2 | 2024 | 14 | 0.280 |
Why?
|
| Chickenpox | 2 | 2024 | 22 | 0.270 |
Why?
|
| Vaccines, Attenuated | 2 | 2024 | 176 | 0.270 |
Why?
|
| Measles | 2 | 2024 | 44 | 0.260 |
Why?
|
| Bile Acids and Salts | 2 | 2025 | 259 | 0.240 |
Why?
|
| Child, Preschool | 8 | 2025 | 14805 | 0.240 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1494 | 0.230 |
Why?
|
| Measles Vaccine | 1 | 2024 | 13 | 0.230 |
Why?
|
| Herpesvirus 3, Human | 1 | 2024 | 30 | 0.220 |
Why?
|
| Retrospective Studies | 9 | 2025 | 17402 | 0.220 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 29 | 0.210 |
Why?
|
| Mumps | 1 | 2023 | 12 | 0.210 |
Why?
|
| Rubella | 1 | 2023 | 24 | 0.210 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2025 | 224 | 0.210 |
Why?
|
| Gadolinium | 1 | 2024 | 117 | 0.210 |
Why?
|
| Sirolimus | 1 | 2025 | 252 | 0.210 |
Why?
|
| Fatty Liver | 1 | 2025 | 215 | 0.210 |
Why?
|
| Cholangitis | 1 | 2023 | 39 | 0.200 |
Why?
|
| Infant | 8 | 2025 | 13173 | 0.200 |
Why?
|
| Interleukin-12 | 1 | 2023 | 122 | 0.190 |
Why?
|
| Female | 14 | 2025 | 71548 | 0.190 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2025 | 294 | 0.190 |
Why?
|
| RNA, Viral | 1 | 2024 | 561 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 97 | 0.190 |
Why?
|
| Herpesvirus 4, Human | 1 | 2025 | 674 | 0.190 |
Why?
|
| Gastrointestinal Motility | 2 | 2012 | 56 | 0.180 |
Why?
|
| Adolescent | 8 | 2025 | 20522 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 5461 | 0.180 |
Why?
|
| Monocytes | 1 | 2023 | 360 | 0.170 |
Why?
|
| Viral Vaccines | 1 | 2023 | 345 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2023 | 416 | 0.160 |
Why?
|
| Male | 13 | 2025 | 65798 | 0.160 |
Why?
|
| Dendritic Cells | 1 | 2023 | 447 | 0.160 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2020 | 59 | 0.160 |
Why?
|
| Macrophages | 1 | 2024 | 704 | 0.160 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 198 | 0.160 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2019 | 22 | 0.150 |
Why?
|
| Medication Adherence | 1 | 2022 | 339 | 0.150 |
Why?
|
| Purpura | 1 | 2019 | 26 | 0.150 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 270 | 0.150 |
Why?
|
| Biopsy | 1 | 2022 | 1301 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2024 | 426 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 516 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2024 | 1484 | 0.140 |
Why?
|
| Incidence | 2 | 2024 | 3399 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2018 | 245 | 0.130 |
Why?
|
| Branchial Region | 1 | 2015 | 8 | 0.130 |
Why?
|
| Pharyngeal Muscles | 1 | 2015 | 11 | 0.120 |
Why?
|
| Prognosis | 3 | 2024 | 5076 | 0.120 |
Why?
|
| Oropharynx | 1 | 2015 | 39 | 0.120 |
Why?
|
| Pharyngeal Diseases | 1 | 2015 | 20 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2019 | 8592 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 247 | 0.120 |
Why?
|
| Polyps | 1 | 2015 | 44 | 0.120 |
Why?
|
| Inflammation | 1 | 2023 | 1591 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 445 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1197 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3843 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2024 | 1255 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2013 | 73 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2024 | 12988 | 0.100 |
Why?
|
| Gastrointestinal Transit | 1 | 2011 | 27 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2024 | 6576 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2013 | 314 | 0.090 |
Why?
|
| Gastroenterology | 1 | 2013 | 210 | 0.090 |
Why?
|
| Aged | 3 | 2017 | 21641 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 362 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 765 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2163 | 0.070 |
Why?
|
| Pregnancy | 1 | 2019 | 7529 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2024 | 3648 | 0.060 |
Why?
|
| Measles virus | 1 | 2024 | 17 | 0.060 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 39 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 188 | 0.050 |
Why?
|
| Graft Survival | 1 | 2024 | 558 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 149 | 0.050 |
Why?
|
| Biomarkers | 2 | 2024 | 3430 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 242 | 0.050 |
Why?
|
| Phenotype | 2 | 2023 | 4553 | 0.040 |
Why?
|
| Adult | 2 | 2019 | 31842 | 0.040 |
Why?
|
| Middle Aged | 2 | 2017 | 29264 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 11098 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 118 | 0.040 |
Why?
|
| Vaccination | 1 | 2024 | 1012 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 1206 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 243 | 0.030 |
Why?
|
| Registries | 1 | 2023 | 1569 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 935 | 0.030 |
Why?
|
| Liver | 1 | 2023 | 1877 | 0.030 |
Why?
|
| Vomiting | 1 | 2015 | 110 | 0.030 |
Why?
|
| Epithelium | 1 | 2015 | 366 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 5190 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2015 | 157 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 2015 | 168 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2013 | 131 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 156 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 267 | 0.020 |
Why?
|
| Iowa | 1 | 2011 | 13 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 152 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 18935 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 2658 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2297 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 6290 | 0.010 |
Why?
|
| Animals | 1 | 2024 | 36407 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 7173 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 9875 | 0.010 |
Why?
|